MCMedicalCodingSoftware
T49.0X5S

T49.0X5S: Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela

Billable / specific codeICD-10-CMPOA exempt

T49.0X5S is a billable, specific ICD-10-CM code for adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela. It is valid for submission on a claim.

Check T49.0X5S with the rest of the claim: free scrubber

7th character "S": sequela

The appropriate 7th character is to be added to each code from category T49

A
initial encounter
D
subsequent encounter
S
sequela

Other codes that can never be billed with T49.0X5S

Their own Excludes1 notes name this code, so the conflict is not listed above.

  • T38.0Poisoning by, adverse effect of and underdosing of glucocorticoids and synthetic analogues

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

T49.0X5S is named in 16 Medicare coverage policies: 16 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

  • A56612Billing and Coding: CT of the Head
  • A56625Billing and Coding: Echocardiography
  • A56844Billing and Coding: RAST Type Tests
  • A57189Billing and Coding: Serum Magnesium

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under T49.0X5

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.